Keyphrases
Inhibitor Therapy
100%
Psoriatic Arthritis
100%
Population-based
100%
Tumour Necrosis Factor Inhibitor (TNFi)
100%
Comorbidity
100%
Charlson Comorbidity Index
71%
Disease Activity
42%
European League against Rheumatism (EULAR)
28%
Treatment Response
28%
Clinical Response
28%
Treatment Persistence
28%
Patients with Depression
14%
Response Rate
14%
Disease Activity Score
14%
Disease Treatment
14%
Cox Proportional Hazards Regression Analysis
14%
Persistence with Treatment
14%
DANBIO Registry
14%
Kaplan-Meier Curve
14%
High Disease Activity
14%
Patient Characteristics
14%
Multivariate Analysis
14%
Population-based Cohort Study
14%
Hazard Ratio
14%
Danish National Patient Registry
14%
Confidence Interval
14%
Kaplan-Meier Plot
14%
Best Response
14%
Medicine and Dentistry
Psoriatic Arthritis
100%
Comorbidity
100%
TNF Inhibitor
100%
Cohort Analysis
100%
Charlson Comorbidity Index
71%
Disease Activity
57%
Rheumatic Disease
28%
Treatment Response
28%
Multivariate Analysis
14%
Gene Linkage
14%
Patient with Depression
14%
Patient Characteristics
14%
Hazard Ratio
14%
Proportional Hazards Model
14%
Combination Therapy
14%
Kaplan Meier Method
14%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriatic Arthritis
100%
Comorbidity
100%
Cohort Study
100%
Tumor Necrosis Factor Inhibitor
100%
Disease Activity
33%
Rheumatic Disease
16%
Combination Therapy
8%
Mathematics
Kaplan-Meier
100%
Multivariate Analysis
50%
Confidence Interval
50%
Hazard Ratio
50%
Response Rate
50%
Proportional Hazards Model
50%
Immunology and Microbiology
Comorbidity
100%
Psoriatic Arthritis
100%
TNF Inhibitor
100%
Rheumatic Disease
16%
Neuroscience
TNF Inhibitor
100%
Comorbidity
100%